Ethris: ETH47ForPrevention Of Respiratory Viral Illnesses In Asthmatics Shows Promising Preliminary Phase 1 Results
ETH47, a nasally administered mRNA drug candidate was safe,well-tolerated by healthy participants, and did not result in any clinically relevant ...